Synthesis of anilino-monoindolylmaleimides as potent and selective PKCβ inhibitors
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (20) , 5171-5174
- https://doi.org/10.1016/j.bmcl.2004.07.061
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3Bioorganic & Medicinal Chemistry Letters, 2003
- Acyclic N-(azacycloalkyl)bisindolylmaleimides: isozyme selective inhibitors of PKCβBioorganic & Medicinal Chemistry Letters, 2003
- Role of protein kinase C isozymes in cellular functions and pathological conditions.Folia Pharmacologica Japonica, 2002
- Protein kinase C inhibitors as novel anticancer drugsExpert Opinion on Investigational Drugs, 2001
- 3-Anilino-4-arylmaleimides: potent and selective inhibitors of glycogen synthase kinase-3 (GSK-3)Bioorganic & Medicinal Chemistry Letters, 2001
- Protein kinase C as a target for new anti-cancer agentsJournal of Oncology Pharmacy Practice, 1999
- Recent developments in protein kinase C inhibitorsExpert Opinion on Therapeutic Patents, 1997
- Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β InhibitorScience, 1996
- (S)-13-[(Dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,21-dimetheno- 1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and Related Analogues: Isozyme Selective Inhibitors of Protein Kinase CβJournal of Medicinal Chemistry, 1996
- Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimidesJournal of Medicinal Chemistry, 1992